FOLH1 and neoplasm: Our results are in line with the work published by Ferdinandus et al., stating that [18F]FDG-positive tumor volume is predictive for OS in mCRPC patients undergoing conventional PSMA-RLT with [177Lu]Lu-PSMA-617 [37].